$81 million NIH grant will study dementia care through workforce in assisted living, other settings
By
Kimberly Bonvissuto
Oct 05, 2023
A five-year, $81 million federal grant will fund a study to better understand the workforce caring for assisted living residents and others who are living with dementia in hopes of helping with recruitment...
More news for Friday, Oct. 6
By
Kimberly Bonvissuto
Oct 06, 2023
World Alzheimer Report 2023 focuses on reducing dementia risk … CDC releases new respiratory virus resources … Senior living providers in MD, MI among recipients of 2023 Thome Aging Well Grants …...
More news for Monday, June 28
Jun 28, 2021
DA reverses plans to seek death penalty for alleged senior living serial killer … FDA grants breakthrough therapy designation to donanemab and lecanemab for Alzheimer’s … Vapors from alcohol-based...
AI could be therapeutic deejay for seniors with dementia, agitation
By
Aaron Dorman
Sep 19, 2023
A new AI-enabled tool can use wearable sensors and adaptive music systems to help older adults with dementia and agitation.
$625,000 stipend will continue work to alter perceptions of aging, dementia
By
Lois A. Bowers
Oct 05, 2016
Anne Basting’s work to improve older adults’ quality of life and change perceptions related to aging and dementia recently received a big boost in the form of a $625,000 “genius grant”...
Research focuses on diagnosing, lessening effects of Alzheimer’s disease
By
Kimberly Bonvissuto
Jun 28, 2022
More than 6 million Americans are living with Alzheimer’s disease, costing the nation $321 billion in 2022, according to the Alzheimer’s Association. A variety of studies and pilot programs are underway...
CMS announces Alzheimer’s drug coverage policy, but ‘the devil is in the details,’ experts say
By
Kimberly Bonvissuto
Jun 01, 2023
A Thursday announcement by the Centers for Medicare & Medicaid Services regarding coverage of Alzheimer’s drugs is being met with skepticism by some industry advocates who say that “the devil is in...
Road traffic, railway noise linked to increased dementia risk
Sep 10, 2021
The general pattern showed higher hazard ratios with higher noise exposure, with levelling off or a decline at higher noise levels.
Medicare will cover new class of Alzheimer’s drugs if fully approved by FDA, with limits
Jun 02, 2023
Drug makers also will have to gather and keep data in a registry showing how the drugs are working in the real world.
Two Alzheimer’s drug trials halted
By
Lois A. Bowers
Mar 22, 2019
Two late-stage clinical trials of a drug for Alzheimer’s disease have been stopped because they aren’t likely to produce promising results, two companies involved with the research announced Thursday.